Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Valsartan
IMED Healthcare Ltd.
C09CA; C09CA03
Valsartan
80 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Angiotensin II antagonists, plain; valsartan
Authorised
2013-01-25
PACKAGE LEAFLET: INFORMATION FOR THE USER DIOVAN 80 MG FILM-COATED TABLETS DIOVAN 160 MG FILM-COATED TABLETS VALSARTAN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Diovan is and what it is used for 2. What you need to know before you take Diovan 3. How to take Diovan 4. Possible side effects 5. How to store Diovan 6. Contents of the pack and other information 1. WHAT DIOVAN IS AND WHAT IT IS USED FOR Diovan contains the active substance: valsartan and belongs to a class of medicines known as angiotensin II receptor antagonists, which help to control high blood pressure. Angiotensin II is a substance in the body that causes vessels to tighten, thus causing your blood pressure to increase. Diovan works by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered. Diovan 80 mg film-coated tablets CAN BE USED FOR THREE DIFFERENT CONDITIONS: TO TREAT HIGH BLOOD PRESSURE IN ADULT AND IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE. High blood pressure increases the workload on the heart and arteries. If not treated it can damage the blood vessels of the brain, heart, and kidneys, and may result in a stroke, heart failure, or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure to normal reduces the risk of developing these disorders. TO TREAT ADULT PATIENTS AFTER A RECENT HEART ATTACK (myocardial infarction). “Recent” here means between 12 hours and 10 days. TO TREAT SYMPTOMATIC HE Прочитајте комплетан документ
Health Products Regulatory Authority 22 February 2021 CRN00C4RN Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Diovan 80 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 80 mg valsartan. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets. _Product imported from Spain and Italy:_ Pale red, round, film-coated tablet with bevelled edges, scored on one side with debossing "D" on one side of the score and "V" on the other side of the score and "NVR" on the reverse side of the tablet. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS As per PA0896/009/001 5 PHARMACOLOGICAL PROPERTIES As per PA0896/009/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Tablet Core Microcrystalline cellulose Crospovidone type A Colloidal anhydrous silica Magnesium stearate Film coat Hypromellose Titanium dioxide (E171) Macrogol 8000 Iron oxide red (E172) Iron oxide yellow (E172) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. Health Products Regulatory Authority 22 February 2021 CRN00C4RN Page 2 of 2 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 30°C. Store in the original package in order to protect from moisture. 6.5 NATURE AND CONTENTS OF CONTAINER Cardboard carton containing blister strips. Each blister strip contains 14 tablets. Pack size 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER IMED Healthcare Ltd. Unit 625 Kilshane Avenue Northwest Business Park Ballycoolin Dublin 15 Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1463/077/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORIS Прочитајте комплетан документ